학술논문
PCN75 COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS CHEMOTHERAPY IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST HEMATOLOGICAL COMPLETE REMISSION WITH MINIMAL RESIDUAL DISEASE USING A MARKOV COHORT APPROACH
Document Type
Abstract
Author
Source
In Value in Health May 2020 23 Supplement 1:S36-S37
Subject
Language
ISSN
1098-3015